Doug Schenkel
Stock Analyst at UBS
(4.94)
# 156
Out of 5,023 analysts
412
Total ratings
66.2%
Success rate
26.8%
Average return
Main Sectors:
Stocks Rated by Doug Schenkel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GRAL GRAIL | Reiterated: Buy | $105 → $175 | $143.26 | +22.16% | 4 | Oct 2, 2026 | |
| RGEN Repligen | Reiterated: Buy | $225 | $181.70 | +23.83% | 4 | Sep 29, 2026 | |
| DHR Danaher | Initiated Coverage: Buy | $250 | $214.06 | +16.79% | 24 | Sep 13, 2026 | |
| LON: VTY Vistry Group PLC | Initiated Coverage: Hold | 300p | 242p | +24.17% | 1 | Sep 9, 2026 | |
| GH Guardant Health | Reiterated: Buy | $75 → $225 | $177.80 | +26.55% | 9 | Sep 9, 2026 | |
| ILMN Illumina | Upgraded: Buy | $150 → $260 | $273.04 | -4.78% | 40 | Sep 9, 2026 | |
| NTRA Natera | Reiterated: Buy | $135 → $435 | $410.35 | +6.01% | 18 | Sep 9, 2026 | |
| VCYT Veracyte | Reiterated: Buy | $50 → $65 | $45.81 | +41.89% | 2 | Sep 9, 2026 | |
| WAT Waters | Upgraded: Buy | $480 → $490 | $425.21 | +15.24% | 23 | Sep 9, 2026 | |
| WST West Pharmaceutical Services | Reiterated: Buy | $415 | $364.98 | +13.70% | 2 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $575 → $730 | $654.80 | +11.48% | 22 | Sep 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $60 | $63.24 | -5.12% | 20 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $15.34 | n/a | 7 | Jul 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $32 | $28.30 | n/a | 1 | Jul 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.54 | n/a | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $1,486.19 | n/a | 1 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $28 | $20.20 | n/a | 1 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $76.63 | n/a | 1 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $60 | $188.67 | n/a | 4 | Dec 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | €265.00 | €251.40 | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $7.90 | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $167.78 | n/a | 34 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $50 | $44.75 | n/a | 25 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $93.50 | n/a | 9 | Jun 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $2.54 | n/a | 6 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $151.53 | n/a | 25 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $8.07 | n/a | 1 | Aug 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $11.07 | n/a | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.09 | n/a | 1 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | - | n/a | 2 | Aug 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $18 → $25 | $1.36 | n/a | 7 | Jul 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $26 | $8.17 | n/a | 5 | Mar 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $12.69 | n/a | 1 | Jan 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $2.25 | n/a | 1 | Dec 29, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $540 | $85.36 | n/a | 25 | Sep 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $16.25 | n/a | 1 | Jul 7, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $85 → $90 | $16.50 | n/a | 18 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 → $4 | $0.7447 | n/a | 14 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $28.35 | n/a | 1 | Jul 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $16.28 | n/a | 1 | Jul 15, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $131.69 | n/a | 15 | Mar 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $250 → $275 | $176.80 | n/a | 12 | Aug 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $3.64 | n/a | 1 | Jan 2, 2018 |
GRAIL
Oct 2, 2026
Reiterated: Buy
Price Target: $105 → $175
Current: $143.26
Upside: +22.16%
Repligen
Sep 29, 2026
Reiterated: Buy
Price Target: $225
Current: $181.70
Upside: +23.83%
Danaher
Sep 13, 2026
Initiated Coverage: Buy
Price Target: $250
Current: $214.06
Upside: +16.79%
Vistry Group PLC
Sep 9, 2026
Initiated Coverage: Hold
Price Target: 300p
Current: 242p
Upside: +24.17%
Guardant Health
Sep 9, 2026
Reiterated: Buy
Price Target: $75 → $225
Current: $177.80
Upside: +26.55%
Illumina
Sep 9, 2026
Upgraded: Buy
Price Target: $150 → $260
Current: $273.04
Upside: -4.78%
Natera
Sep 9, 2026
Reiterated: Buy
Price Target: $135 → $435
Current: $410.35
Upside: +6.01%
Veracyte
Sep 9, 2026
Reiterated: Buy
Price Target: $50 → $65
Current: $45.81
Upside: +41.89%
Waters
Sep 9, 2026
Upgraded: Buy
Price Target: $480 → $490
Current: $425.21
Upside: +15.24%
West Pharmaceutical Services
Sep 9, 2026
Reiterated: Buy
Price Target: $415
Current: $364.98
Upside: +13.70%
Sep 8, 2026
Initiated Coverage: Buy
Price Target: $575 → $730
Current: $654.80
Upside: +11.48%
Dec 10, 2025
Upgraded: Buy
Price Target: $60
Current: $63.24
Upside: -5.12%
Jul 21, 2025
Reiterated: Hold
Price Target: n/a
Current: $15.34
Upside: n/a
Jul 14, 2025
Initiated Coverage: Buy
Price Target: $32
Current: $28.30
Upside: n/a
May 7, 2025
Downgraded: Hold
Price Target: n/a
Current: $4.54
Upside: n/a
Dec 13, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $1,486.19
Upside: n/a
Dec 13, 2024
Initiated Coverage: Buy
Price Target: $28
Current: $20.20
Upside: n/a
Dec 13, 2024
Initiated Coverage: Buy
Price Target: $60
Current: $76.63
Upside: n/a
Dec 13, 2024
Initiated Coverage: Buy
Price Target: $60
Current: $188.67
Upside: n/a
Nov 14, 2024
Initiated Coverage: Buy
Price Target: €265.00
Current: €251.40
Upside: n/a
Nov 14, 2024
Initiated Coverage: Hold
Price Target: n/a
Current: $7.90
Upside: n/a
Jun 27, 2024
Downgraded: Hold
Price Target: n/a
Current: $167.78
Upside: n/a
Jun 27, 2024
Upgraded: Buy
Price Target: $50
Current: $44.75
Upside: n/a
Jun 27, 2024
Downgraded: Hold
Price Target: n/a
Current: $93.50
Upside: n/a
Dec 12, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $2.54
Upside: n/a
Dec 12, 2023
Initiated Coverage: Hold
Price Target: n/a
Current: $151.53
Upside: n/a
Aug 17, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $8.07
Upside: n/a
Aug 16, 2021
Initiated Coverage: Hold
Price Target: n/a
Current: $11.07
Upside: n/a
Aug 9, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $2.09
Upside: n/a
Aug 4, 2021
Downgraded: Hold
Price Target: n/a
Current: -
Upside: n/a
Jul 1, 2021
Reiterated: Buy
Price Target: $18 → $25
Current: $1.36
Upside: n/a
Mar 17, 2021
Reiterated: Buy
Price Target: $17 → $26
Current: $8.17
Upside: n/a
Jan 12, 2021
Initiated Coverage: Buy
Price Target: n/a
Current: $12.69
Upside: n/a
Dec 29, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $2.25
Upside: n/a
Sep 28, 2020
Reiterated: Buy
Price Target: $540
Current: $85.36
Upside: n/a
Jul 7, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $16.25
Upside: n/a
Feb 25, 2020
Reiterated: Buy
Price Target: $85 → $90
Current: $16.50
Upside: n/a
Jan 6, 2020
Reiterated: Hold
Price Target: $10 → $4
Current: $0.7447
Upside: n/a
Jul 22, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $28.35
Upside: n/a
Jul 15, 2019
Initiated Coverage: Buy
Price Target: n/a
Current: $16.28
Upside: n/a
Mar 20, 2019
Reiterated: Buy
Price Target: $110
Current: $131.69
Upside: n/a
Aug 2, 2018
Reiterated: Buy
Price Target: $250 → $275
Current: $176.80
Upside: n/a
Jan 2, 2018
Initiated Coverage: Buy
Price Target: n/a
Current: $3.64
Upside: n/a